N P Quinn, B Toone, A E Lang, C D Marsden, J D Parkes. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsBromocriptine/adverse effectsCarbidopa/adverse effectsErgolines/adverse effectsHumansMaleMiddle AgedParaphilic Disorders/chemically inducedParkinson Disease/drug therapyPergolide
Substances: See more » Antiparkinson AgentsErgolinesPergolideBromocriptineCarbidopa
Year: 1983 PMID: 6860883 DOI: 10.1192/bjp.142.3.296
Source DB: PubMed Journal: Br J Psychiatry ISSN: 0007-1250 Impact factor: 9.319